BBI

Brickell Biotech Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.100
+0.030
+2.80%
Closed 16:00 04/03 EDT
OPEN
1.108
PREV CLOSE
1.070
HIGH
1.108
LOW
1.010
VOLUME
55.05K
TURNOVER
--
52 WEEK HIGH
8.89
52 WEEK LOW
1.000
MARKET CAP
10.64M
P/E (TTM)
-0.5397
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BBI stock price target is 1.800 with a high estimate of 1.800 and a low estimate of 1.800.

EPS

BBI News

More
  • Brickell Biotech, Inc. (BBI) CEO Rob Brown on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 03/18 22:53
  • Brickell Biotech Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
  • GlobeNewswire · 03/18 21:01
  • Brickell Biotech Q4 Sales $669K May Not Compare To $1.18M Estimate
  • Benzinga · 03/18 20:03
  • Brickell Biotech Inc to Host Earnings Call
  • ACCESSWIRE · 03/18 19:30

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About BBI

Brickell Biotech, Inc., formerly Vical Incorporated, is a clinical-stage pharmaceutical company that focuses on the development of therapeutics for the treatment of skin diseases. The Company’s pipeline consists of molecular entities targeting the treatment of the indications, such as hyperhidrosis, cutaneous T-cell lymphoma, allergic contact dermatitis, psoriasis and androgenic alopecia. The Company’s product candidates include BBI-3000, BBI-6000 and Sofpironium Bromide. Sofpironium Bromide is a topical soft anticholinergic for axillary hyperhidrosis. BBI-3000 is an oral rexinoid for cutaneous T-cell lymphoma. BBI-6000 is a retinoic acid-related orphan nuclear receptor gamma antagonist, which is develops for psoriasis.
More

Webull offers kinds of Brickell Biotech Inc stock information, including NASDAQ:BBI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BBI stock news, and many more online research tools to help you make informed decisions.